City Therapeutics
City Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 3 tracked investors.
About City Therapeutics
City Therapeutics is a startup founded in 2020 based in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
City Therapeutics is a biopharmaceutical company focused on developing RNA interference (RNAi) therapeutics. It uses next-generation engineering of small interfering RNAs (siRNAs) to create medicines designed to silence gene expression and block protein production for treating various diseases.
Explore City Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.